<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0000863'>Central diabetes insipidus</z:hpo> (DI) is a rare but recognized complication of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) that is caused by <z:e sem="disease" ids="C0162679" disease_type="Neoplastic Process" abbrv="">leukemic infiltration</z:e> to the hypothalamo-neurohypophyseal system </plain></SENT>
<SENT sid="1" pm="."><plain>In rare patients in whom a wide region of the hypothalamus is involved, central DI results in hypodipsic <z:hpo ids='HP_0003228'>hypernatremia</z:hpo> and <z:hpo ids='HP_0001944'>dehydration</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Typical DI symptoms such as <z:hpo ids='HP_0001959'>polydipsia</z:hpo>, <z:hpo ids='HP_0000103'>polyuria</z:hpo>, and marked thirst are concealed in these cases, because the hypothalamic "thirst center" cannot send thirst stimuli to the cerebral cortex </plain></SENT>
<SENT sid="3" pm="."><plain>Herein we describe a patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> developing into <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, who presented with hypodipsic <z:hpo ids='HP_0003228'>hypernatremia</z:hpo> and <z:hpo ids='HP_0001944'>dehydration</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>A diagnosis of central DI was made on the ground of a low level of serum anti-<z:chebi fb="40" ids="35498">diuretic</z:chebi> hormone (ADH) despite high serum osmolality </plain></SENT>
<SENT sid="5" pm="."><plain>A magnetic resonance imaging study revealed attenuation of a physiological "bright spot" of the neurohypophysis </plain></SENT>
<SENT sid="6" pm="."><plain>An induction course chemotherapy including regular-dose <z:chebi fb="0" ids="28680">cytarabine</z:chebi> and <z:chebi fb="0" ids="41977">daunorubicin</z:chebi> produced a rapid improvement of <z:hpo ids='HP_0003228'>hypernatremia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>The bone marrow aspirate after two courses of chemotherapy showed complete remission </plain></SENT>
<SENT sid="8" pm="."><plain>At that point, ADH release and the "bright spot" were recovered </plain></SENT>
<SENT sid="9" pm="."><plain>In order to correctly diagnose central DI in association with <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e>, we should not overlook this atypical type of DI </plain></SENT>
</text></document>